Alerts
PDF
Other content recommended for you
- Intermediate acting non-depolarizing neuromuscular blocking agents and risk of postoperative respiratory complications: prospective propensity score matched cohort study
- Deep neuromuscular block improves angiographic image quality during endovascular coiling of unruptured cerebral aneurysm: a randomized clinical trial
- Sugammadex rescue following prolonged rocuronium neuromuscular blockade with ‘recurarisation’ in a patient with severe renal failure
- Effect of intraoperative muscle relaxation reversal on the success rate of motor-evoked potential recording in patients undergoing spinal surgery: study protocol for a randomised controlled trial
- Rocuronium for control of muscle spasms in a tetanus patient with chronic methamphetamine use disorder
- Sugammadex for neuromuscular blockade reversal: a review of its use in a general hospital†
- Effect of patient weight on first pass success and neuromuscular blocking agent dosing for rapid sequence intubation in the emergency department
- A confirmed case of sugammadex-induced anaphylaxis in a UK hospital
- Recovery of early postoperative muscle strength after deep neuromuscular block by means of ultrasonography with comparison of neostigmine versus sugammadex as reversal drugs: study protocol for a randomised controlled trial
- OHP-009 Analysis of Sugammadex Expenditure After Its Introduction into Clinical Practise in a French University Hospital